SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-000949
Filing Date
2024-01-09
Accepted
2024-01-09 16:10:04
Documents
1
Period of Report
2023-12-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704834595.html 4  
1 FORM 4 wk-form4_1704834595.xml 4 4621
  Complete submission text file 0001628280-24-000949.txt   6421
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FRESH TRACKS THERAPEUTICS, INC. 2000 CENTRAL AVENUE, SUITE 100 BOULDER CO 80301
Business Address
Marchio Albert N II (Reporting) CIK: 0001196054 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 24523366